DRUG EFFECTING THE DRUG RESISTANCE PATHOGENS

-

  A molecule called Lip oxazolidinone A is a synthetic compound could be used as a tool for the study of infectious agents, especially gram positives might find its application in the future drug creations. It is isolated from bacteria found in the marine sediments. Hence it is obtained from natural product. These bacteria produces the secondary metabolites, which is used for purposes like defense. During the initial isolation of lip oxazolidinone A was found to be effective against Gram-positive bacteria like MRSA. These original findings were confirmed and understood to correlate the molecular structure to its function, to know the portions of it was responsible for its anti-microbial actions and to improve that structure. Lip oxazolidinone A was synthesized using the novel chemical tools in the lab. It helped to confirm the portion of the structure responsible for an antibiotic reaction which was JJM35. It was tested on both the resistant and non-resistant strains of bacteria. It was tested invitro against MRSA showed   that the molecule was 50 times more effective against several bacterial strains compared to other natural drug. In Addition to this, it was effective against resistant bacterial strains than nonresistant strains. It was identified that these molecules might also inhibit multiple biosynthetic pathways directly or indirectly which means bacteria may have difficulty in developing resistance to potential drugs obtained from these molecules. The chemical scaffold obtained is evaluated for knowing in-vivo efficacy of the molecule. This scaffold is built in order to synthesize drugs   effective against MRSA and other resistant bacteria and also to increase their spectrum of activity.


Comments

Post a Comment

Popular posts from this blog

Nanomedicine & Women’s Health

-
Image
Nanomedicine have the potential to revolutionize the diagnosis, prevention, and treatment of a range of conditions and diseases affecting women’s health Nanomedicine is the application of  nanotechnology  in the field of medicine with a view to enhancing the diagnosis and treatment of various diseases. Nanotechnology is already involved in a range of biomedical applications including drug and vaccine delivery, diagnostic imaging, nanosensor diagnostics, nano-enabled therapies, and tissue engineering. A growing recognition of the specific health care requirements of women has resulted in the proposed organizational changes in the provision of health care, focusing predominantly on a life course approach to women’s health care. As our understanding of the benefits of nanomaterial-based agents and diagnostics continues to grow in terms of selectivity, sensitivity, affinity, and detection limits, there is a widespread anticipation that nanotechnology will play an increasing rol
Read more

Drug Development with Translational Pharmaceutics

-
Image
As the   pharmaceutical   industry faces increasing pressure to accelerate drug development, many contract development organizations are recommending early development programs.   Scientists discussed the current roadblocks in the traditional   drug development   process and explains how productivity can be improved and timelines shortened by implementing a new approach the company refers to as Translational Pharmaceutics.   Be the part of   20th World Conference on Pharmaceutical Chemistry and Drug Design   in Dubai, UAE during September 03-05, 2018. Describe the state of affairs of researches, thesis, projects and enlighten us with your innovation and meet pharmacists, apothecaries, druggists, scientists, experts and technologists. https://drug-chemistry.pharmaceuticalconferences.com There are many factors that can delay the development and eventual commercialization of   novel therapeutics . One of the most intractable factors is the conventional trial-and-error approach
Read more

20th World Conference on Pharmaceutical Chemistry and Drug Design

-
Image
Drug design is an inventive process of medication discovered by biological target. It is also known as rational drug design or rational design. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense. Drug design relies on the knowledge of the three-dimensional structure of bioactive sites. The drug is an active molecule, when it is predicament to target site it can either inhibit or activate the function of a biomolecule which effects in therapeutic benefit. The main objective in drug design is to foresee whether a given particle will bind to a target and if so how unequivocally. Molecular mechanics or molecular dynamics are regularly used to predict the conformation of the little particle and to model conformational changes in the biological targets that may happen when the little molecules ties to it.   The us
Read more